Detail
| LncRNA Name | Unigene6646 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✔ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | RNA-seq, qPCR etc. |
| Sample | cell lines (CNE-2, 5-8F and 6-10B) |
| Expression Pattern | down-regulated |
| Function Description | Compared with the deep sequencing prediction findings, qRT-PCR verified that the same significant differential expression trends were presented in 7 of 8 lncRNAs, which included all the known lncRNAs (n375709, n377806, n369241 and n335785) and 3 novel lncRNAs (Unigene6646, Unigene6644 and Unigene1654). |
| Pubmed ID | 27498905 |
| Year | 2016 |
| Title | Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma. |
| External Links |
| Links for Unigene6646 | GenBank HGNC lncrnadb Noncode |
| Links for nasopharyngeal cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.